179 related articles for article (PubMed ID: 13377735)
21. [Sequelae of a molar abortion. Discussion of late therapeutic indications].
SEGUY J; HERVE R
Bull Fed Soc Gynecol Obstet Lang Fr; 1959; 11():334-9. PubMed ID: 13856341
[No Abstract] [Full Text] [Related]
22. [Urinary steroid hormones & cytology of threatened abortion treated with stilbestrol].
WOISKI A; PADZIK H
Ginekol Pol; 1958; 29(1):89-102. PubMed ID: 13562554
[No Abstract] [Full Text] [Related]
23. [Investigations on the placenta in abortion. IV. Excretion of pregnandiol in threatened abortion].
BOTELLA LLUSIA J; DE CEGAMA ML; TORNERO MC
Arch Med Exp; 1952; 15(3):227-34. PubMed ID: 13031893
[No Abstract] [Full Text] [Related]
24. [Acute hepato-nephritis syndrome of molar origin].
MAGNIN P; FISCHER G
Bull Fed Soc Gynecol Obstet Lang Fr; 1960; 12():392-4. PubMed ID: 13765292
[No Abstract] [Full Text] [Related]
25. [THE DEVELOPMENT OF HCG AND PREGNANDIOL EXCRETION IN ABORTION TREATED WITH GESTAGENS AND TRANQUILIZING AGENTS].
TOTH F; TREIT S
Z Geburtshilfe Gynakol; 1964 Jul; 162():140-52. PubMed ID: 14291958
[No Abstract] [Full Text] [Related]
26. [Dynamic studies on pregnandiol in urine as a method of control of the treatment of spontaneous abortion].
ZAKHAROVA VA
Akush Ginekol (Mosk); 1953; 3():26-9. PubMed ID: 13080098
[No Abstract] [Full Text] [Related]
27. Threatened abortion; an evaluation of the prognosis based on pregnanediol determinations and of treatment with progesterone.
KOFF AK; TULSKY AS
Surg Clin North Am; 1953 Feb; ():3-15. PubMed ID: 13015384
[No Abstract] [Full Text] [Related]
28. [Physiopathological considerations in the study of hormonal elimination in endocrine abortion].
PIAUX G; SIMONNET H
Ann Endocrinol (Paris); 1955; 16(4):498-501. PubMed ID: 13327399
[No Abstract] [Full Text] [Related]
29. Progesterone and human chorionic gonadotrophin in serum and pregnandiol in urine in threatened abortion.
Hertz JB; Larsen JF; Arends J; Nielsen J
Acta Obstet Gynecol Scand; 1980; 59(1):23-7. PubMed ID: 7386186
[TBL] [Abstract][Full Text] [Related]
30. [Value of the determination of pregnanediol and phenolsteroids for the diagnosis and treatment of repeated abortions of hormonal origin].
JAYLE MF; ROBEY M
Presse Med (1893); 1962 May; 70():1193-6. PubMed ID: 14451472
[No Abstract] [Full Text] [Related]
31. Excretion of estriol and pregnanediol in Chinese women during pregnancy.
Wei PY; Ouyang PC; Lee TY; Chen JS
Am J Obstet Gynecol; 1968 Sep; 102(1):8-12. PubMed ID: 5672482
[No Abstract] [Full Text] [Related]
32. [The legal meaning of the mole abortion].
WESPI
Gynaecologia; 1946 Nov; 122(5):268-73. PubMed ID: 20292761
[No Abstract] [Full Text] [Related]
33. [Abortion-mola-mola-destruens].
SCHUT
Ned Tijdschr Verloskd Gynaecol; 1953; 53(1):53-6. PubMed ID: 13099428
[No Abstract] [Full Text] [Related]
34. The persistent positive Friedman test in hydatid moles.
OWEN N
Tex State J Med; 1948 Jan; 43(9):582-5. PubMed ID: 18906928
[No Abstract] [Full Text] [Related]
35. [Comparative variation of statistical cell nucleus measurements on the fetal villi of aborted fragments and hydatidiform mole].
SCHAEFER HE
Zentralbl Allg Pathol; 1960 Jan; 100():341-4. PubMed ID: 14442339
[No Abstract] [Full Text] [Related]
36. Pregnandiol excretion and corpus luteum therapy in habitual abortion.
ALDER R
Fertil Steril; 1953; 4(2):170-2. PubMed ID: 13033957
[No Abstract] [Full Text] [Related]
37. Hydatidiform degeneration in aborted ova; a histopathological and clinical study.
NILSSON L
Acta Obstet Gynecol Scand Suppl; 1957; 36(Suppl 7):1-80. PubMed ID: 13532606
[No Abstract] [Full Text] [Related]
38. THE MANAGEMENT OF THREATENED ABORTION BY PREGNANEDIOL ESTIMATION AND VAGINAL CYTOLOGY.
Cox LW; Cox RI; Skipper JS
Aust N Z J Obstet Gynaecol; 1964 Dec; 4(4):160-4. PubMed ID: 14243039
[No Abstract] [Full Text] [Related]
39. [THEORETICAL CHARACTERISTICS OF CHORIONIC GONADOTROPIN THERAPY AND ITS USE IN THREATENED ABORTION].
NYIRI I; TAKACS I
Zentralbl Gynakol; 1964 Jul; 86():990-7. PubMed ID: 14253030
[No Abstract] [Full Text] [Related]
40. [Determination of butylsoluble glycuronidates; our experience and its clinical importance].
RIVIERE M; JAUBERT JL; CORREA P
J Med Bord; 1952 Nov; 129(11):1019-31. PubMed ID: 13023207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
